The weekly litigation news digest is live. Subscribe now

IP Verse

Glycopeptide Compositions - EP3215173

The patent EP3215173 was granted to Xellia Pharmaceuticals APS on Mar 11, 2020. The application was filed on Nov 6, 2015 under application number EP15791287A. The patent is currently recorded with a legal status of "Revoked".

EP3215173

XELLIA PHARMACEUTICALS APS
Application Number
EP15791287A
Filing Date
Nov 6, 2015
Status
Revoked
Jul 15, 2022
Publication Date
Mar 11, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBOct 1, 2020EDERADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONJPH1180021
DESCRIPTIONUS2014260098
DESCRIPTIONUS4670258
DESCRIPTIONUS8778873
DESCRIPTIONWO2014026052
DESCRIPTIONWO2014085526
DESCRIPTIONWO9719690
INTERNATIONAL-SEARCH-REPORTJP2008201778
INTERNATIONAL-SEARCH-REPORTWO2012159103
INTERNATIONAL-SEARCH-REPORTWO2014194296
INTERNATIONAL-SEARCH-REPORTWO2015138983
OPPOSITIONJP2008201778
OPPOSITIONWO2012159103
OPPOSITIONWO2014194296
OPPOSITIONWO2015138983

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents